Literature DB >> 8187588

Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma.

W A Mourad1, N Sneige, R L Katz, N G Ordóñez.   

Abstract

The Ki-67 antibody binds to nonresting cells where Ki-67 labeling index (KLI) reflects proliferative activity (PA). The argyrophilic nucleolar organizer regions (AgNOR) counts have been correlated to ploidy and/or PA. Two AgNOR counting methods distinguish ploidy from PA. The first count is the mean AgNOR count (mAg-NOR) which correlates with ploidy. The second is the percentage of nuclei with > or = 5 AgNORs/nucleus (pAgNOR) which reflects PA. To explore this relationship, we separately stained smears of 20 fine-needle aspirates (FNAs) of lymphoproliferative disorders (n = 12) and breast carcinomas (n = 8) for AgNOR and Ki-67. We also double-stained 10 of the smears for both AgNOR and Ki-67. The correlation of pAgNOR counts and KLI was statistically significant (P < 0.0001) whereas it was not between mAgNOR and KLI (P = 0.13). Additionally, using the double stain, the Ki-67 negative cells had an AgNOR granule range of 1-3/nucleus with a mean of 1.33 (+1.86 SD). The Ki-67 positive cells showed an AgNOR granule range of 2-12/nucleus with a mean of 4.15 (+/- 1.02 SD) (P < 0.0002). We thus conclude that pAgNOR is a more reliable indicator of PA than mAgNOR and that four AgNORs/nucleus is an acceptable number differentiating proliferating from resting cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8187588     DOI: 10.1002/dc.2840100204

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

1.  A combined staining method for argyrophilic nucleolar organizer regions and for glial fibrillary acidic protein in astrocytes of human brain.

Authors:  S Fushiki; C Kinoshita; A Nagata; Y Tsutsumi; Y Nishizawa
Journal:  Histochem J       Date:  1996-07

2.  Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas.

Authors:  X Xie; O P Clausen; P De Angelis; M Boysen
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.